These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9048364)

  • 1. A self-collimating convolution backprojection algorithm for optimizing dose distributions of I-125 prostate implants.
    Siochi RA; Elson HR; Foster AE; Lamba MA
    Med Phys; 1997 Feb; 24(2):241-9. PubMed ID: 9048364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new genetic algorithm technique in optimization of permanent 125I prostate implants.
    Yang G; Reinstein LE; Pai S; Xu Z; Carroll DL
    Med Phys; 1998 Dec; 25(12):2308-15. PubMed ID: 9874822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of seed loading approaches in prostate brachytherapy.
    Butler WM; Merrick GS; Lief JH; Dorsey AT
    Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P; Battista J; Van Dyk J
    Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor dose specification of I-125 seed implants.
    Wu A; Zwicker RD; Sternick ES
    Med Phys; 1985; 12(1):27-31. PubMed ID: 3974522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BrachyView: proof-of-principle of a novel in-body gamma camera for low dose-rate prostate brachytherapy.
    Petasecca M; Loo KJ; Safavi-Naeini M; Han Z; Metcalfe PE; Meikle S; Pospisil S; Jakubek J; Bucci JA; Zaider M; Lerch ML; Qi Y; Rosenfeld AB
    Med Phys; 2013 Apr; 40(4):041709. PubMed ID: 23556879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation of a digital tomosynthesis-based seed reconstruction algorithm for intraoperative postimplant dose evaluation in low dose rate prostate brachytherapy.
    Brunet-Benkhoucha M; Verhaegen F; Lassalle S; Béliveau-Nadeau D; Reniers B; Donath D; Taussky D; Carrier JF
    Med Phys; 2009 Nov; 36(11):5235-44. PubMed ID: 19994534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic algorithm for the optimization of prostate implants.
    Yu Y; Schell MC
    Med Phys; 1996 Dec; 23(12):2085-91. PubMed ID: 8994175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
    Villeneuve M; Leclerc G; Lessard E; Pouliot J; Beaulieu L
    Med Phys; 2008 May; 35(5):1970-7. PubMed ID: 18561673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
    Chibani O; Williamson JF
    Med Phys; 2005 Dec; 32(12):3688-98. PubMed ID: 16475768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
    Lindsay PE; Van Dyk J; Battista JJ
    Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
    Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
    Meigooni AS; Luerman CM; Sowards KT
    Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
    Nath S; Chen Z; Yue N; Trumpore S; Peschel R
    Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
    Reed DR; Wallner KE; Narayanan S; Sutlief SG; Ford EC; Cho PS
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):301-7. PubMed ID: 16111600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.